Who are Arcutis's investors?

Arcutis's investors include Frazier Life Sciences.

Arcutis

Founded 2016 · 477 employees on LinkedIn · 1 known investors

Arcutis is a biopharmaceutical company focused on dermatology, developing treatments for immune-mediated skin diseases such as plaque psoriasis, atopic dermatitis, seborrheic dermatitis, and scalp psoriasis. It serves patients and healthcare professionals with therapies aimed at improving drug efficacy, safety, and tolerability.

Biotech Healthtech Medical Devices

Investors · 1

Frazier Life SciencesPalo Alto

Competitors · 1

by search overlap

Medscape259 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.

Companies competing with Arcutis for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Arcutis do?: Arcutis is a biopharmaceutical company focused on dermatology, developing treatments for immune-mediated skin diseases such as plaque psoriasis, atopic dermatitis, seborrheic dermatitis, and scalp psoriasis. It serves patients and healthcare professionals with therapies aimed at improving drug efficacy, safety, and tolerability.
Who are Arcutis's investors?: Arcutis's investors include Frazier Life Sciences.